Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue

Am J Hematol. 2007 Jan;82(1):87-8. doi: 10.1002/ajh.20704.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / adverse effects
  • Glucosephosphate Dehydrogenase Deficiency / complications*
  • Hemolysis / drug effects*
  • Humans
  • Methemoglobinemia / complications*
  • Methemoglobinemia / drug therapy
  • Methylene Blue / administration & dosage
  • Methylene Blue / adverse effects
  • Middle Aged
  • Pyridines / administration & dosage
  • Pyridines / adverse effects*
  • Thiosemicarbazones / administration & dosage
  • Thiosemicarbazones / adverse effects*

Substances

  • Enzyme Inhibitors
  • Pyridines
  • Thiosemicarbazones
  • 3-aminopyridine-2-carboxaldehyde thiosemicarbazone
  • Methylene Blue